This indicates that, on the one hand, growth restriction of normally avirulent Salmonella by NADPH oxidase may be of relevance for CGD patients, but on the other hand that other microbial stimuli can also trigger enteropathy. Here, FMO5 is linked to chronic granulomatous disease.